Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,427Revenue $M11,764Net Margin (%)5.8Z-Score2.2
Enterprise Value $M23,437EPS $3.0Operating Margin %14.7F-Score5
P/E(ttm))22.7Cash Flow Per Share $8.2Pre-tax Margin (%)10.7Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %15.5Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %16.0Current Ratio1.6Lower Leverage y-yY
Price/Cash Flow13.1y-y EBITDA Growth Rate %18.1ROA % (ttm)4.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)15.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M215ROI % (ttm)3.4Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAAndreas Halvorsen 2014-09-30 Add0.15%$71.01 - $74.94
($73.27)
$ 76.194%Add 14.1%3,981,170
DVAAndreas Halvorsen 2014-06-30 Add0.5%$67.12 - $72.95
($69.49)
$ 76.1910%Add 82%3,489,084
DVAMario Gabelli 2014-06-30 Add0.03%$67.12 - $72.95
($69.49)
$ 76.1910%Add 330.08%114,328
DVASteve Mandel 2014-06-30 Sold Out -1.1%$67.12 - $72.95
($69.49)
$ 76.1910%Sold Out0
DVAJoel Greenblatt 2014-06-30 Reduce-0.11%$67.12 - $72.95
($69.49)
$ 76.1910%Reduce -49.01%110,765
DVARay Dalio 2014-06-30 Reduce-0.02%$67.12 - $72.95
($69.49)
$ 76.1910%Reduce -52.11%31,098
DVAAndreas Halvorsen 2014-03-31 Add0.1%$62.74 - $69.81
($66.3)
$ 76.1915%Add 22.06%1,917,104
DVAMario Gabelli 2014-03-31 Buy 0.01%$62.74 - $69.81
($66.3)
$ 76.1915%New holding, 26583 sh.26,583
DVASteve Mandel 2014-03-31 Reduce-1.31%$62.74 - $69.81
($66.3)
$ 76.1915%Reduce -56.84%3,655,739
DVARay Dalio 2014-03-31 Reduce-0.01%$62.74 - $69.81
($66.3)
$ 76.1915%Reduce -30.5%64,941
DVASteve Mandel 2013-12-31 Add0.59%$55.03 - $63.39
($58.62)
$ 76.1930%Add 34.41%8,470,777
DVAAndreas Halvorsen 2013-12-31 Buy 0.46%$55.03 - $63.39
($58.62)
$ 76.1930%New holding, 1570667 sh.1,570,667
DVAWarren Buffett 2013-12-31 Add0.3%$55.03 - $63.39
($58.62)
$ 76.1930%Add 15.95%36,461,294
DVAJoel Greenblatt 2013-12-31 Add0.21%$55.03 - $63.39
($58.62)
$ 76.1930%Add 171.1%221,775
DVARichard Perry 2013-12-31 Sold Out -0.36%$55.03 - $63.39
($58.62)
$ 76.1930%Sold Out0
DVARon Baron 2013-12-31 Sold Out -0.16%$55.03 - $63.39
($58.62)
$ 76.1930%Sold Out0
DVAJohn Burbank 2013-12-31 Sold Out -0.01%$55.03 - $63.39
($58.62)
$ 76.1930%Sold Out0
DVASteve Mandel 2013-09-30 Buy 1.6%$53.755 - $60.615
($57.24)
$ 76.1933%New holding, 6302027 sh.6,302,027
DVARichard Perry 2013-09-30 Buy 0.36%$53.755 - $60.615
($57.24)
$ 76.1933%New holding, 250000 sh.250,000
DVARon Baron 2013-09-30 Buy 0.16%$53.755 - $60.615
($57.24)
$ 76.1933%New holding, 600000 sh.600,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DVA Andreas Halvorsen 2014-09-303,981,1701.851.2+14.1%
DVA Mario Gabelli 2014-09-30115,6780.050.05+1.18%
DVA Warren Buffett 2014-09-3037,621,15217.512.6
DVA Joel Greenblatt 2014-09-30103,6200.050.08-6.45%
DVA Ray Dalio 2014-09-3026,5260.010.02-14.7%
Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Margolis Robert JCo-Chairman of the Board 2015-01-16Sell31,400$74.921.7view
Rivera Kim MChief Legal Officer 2015-01-08Sell1,111$75.11.45view
STAFFIERI MICHAEL DAVIDCOO, Kidney Care 2015-01-02Sell53,427$75.770.55view
Margolis Robert JCo-Chairman of the Board 2014-12-30Sell31,400$76.090.13view
Mildenberger LauraChief People Ofcr, Kidney Care 2014-12-19Sell1,446$75.50.91view
Margolis Robert JCo-Chairman of the Board 2014-12-18Sell31,400$74.672.04view
Margolis Robert JCo-Chairman of the Board 2014-12-03Sell31,400$75.80.51view
Rivera Kim MChief Legal Officer 2014-12-01Sell6,503$76.080.14view
Margolis Robert JCo-Chairman of the Board 2014-11-21Sell31,400$75.081.48view
HILGER JAMES KChief Accounting Officer 2014-11-12Sell7,535$760.25view

Press Releases about DVA :

    Quarterly/Annual Reports about DVA:

    News about DVA:

    Articles On GuruFocus.com
    How Berkshire Hathaway's Todd Combs and Ted Weschler Performed Relative To The S&P 500 in 2014 Jan 13 2015 
    Weekly Insider Sells Highlight: ADP, KMX, SYK, DVA Jan 05 2015 
    Weekly Insider Sells Highlight: FB, DVA, DATA, MCK, TXN Nov 18 2014 
    DaVita HealthCare Partners is a Great Business With Solid Growth Potential Aug 30 2014 
    DaVita Seems to be a High-Growth Company Aug 20 2014 
    Mario Gabelli Reports his Top Increase of the Second Quarter Aug 07 2014 
    Warren Buffett's 3 High-Conviction Stocks Jun 13 2014 
    Thoughts on Ted Weschler's Largest Holding and Excellent Long-Term Results Mar 14 2014 
    Buffett's Investor Pick Ted Weschler Discusses DaVita Inc. Mar 03 2014 
    Three Billionaires Adjust Portfolio Holdings – Buffett, Watsa and Loeb Feb 28 2014 


    More From Other Websites
    DaVita Ranks First in Clinical Outcomes According to Government Reports Jan 26 2015
    DaVita Ranks First in Clinical Outcomes According to Government Reports Jan 26 2015
    DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 22 2015
    DaVita Rx Celebrates Tenth Anniversary Jan 19 2015
    DaVita Rx Celebrates Tenth Anniversary Jan 19 2015
    DaVita's Inorganic Growth Initiatives Look Impressive - Analyst Blog Jan 16 2015
    DaVita HealthCare Partners Inc. (DVA): New Analyst Report from Zacks Equity Research - Zacks Equity... Jan 16 2015
    DaVita HealthCare Partners Inc. Schedules 4th Quarter 2014 Investor Conference Call Jan 14 2015
    DaVita HealthCare Partners Inc. Schedules 4th Quarter 2014 Investor Conference Call Jan 14 2015
    Lifshitz & Miller Law Firm Announces Investigation of DaVita HealthCare Partners Inc., JPS... Jan 08 2015
    The Shuman Law Firm Investigates DaVita HealthCare Partners Inc. Jan 06 2015
    Five states to get $22 million in DaVita kickbacks case Jan 05 2015
    DaVita HealthCare Partners Celebrates Milestones of 2014 Dec 29 2014
    DaVita HealthCare Partners Celebrates Milestones of 2014 Dec 29 2014
    Nearly 11,500 Children Receive New Shoes from DaVita HealthCare Partners Teammates Dec 23 2014
    Joe Mello Returns to DaVita as HealthCare Partners COO; Dennis Kogod Becomes HealthCare Partners... Dec 18 2014
    Berkshire Hathaway: Why 2014’s Been a Year to Forget Dec 18 2014
    DaVita Kidney Care Offers Kidney-Friendly Recipes in New Winter Cookbook Dec 18 2014
    DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical... Dec 15 2014
    DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical... Dec 15 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK